Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
about
Combined oral contraceptives: venous thrombosisCombined oral contraceptives: venous thrombosisRisk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9The epidemiology of acne vulgaris in late adolescenceHormonal contraceptives and cerebral venous thrombosis risk: a systematic review and meta-analysisHormonal contraception and venous thromboembolismVenous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10Third generation oral contraceptives and risk of venous thrombosis: meta-analysisBenefits and risks of third-generation oral contraceptives.Oral contraception was not associated with venous thromboembolic disease in recent study.Incidence of venous thromboembolism in users of combined oral contraceptives. Methods for identifying cases and estimating person time at risk must be detailed.DoH seems to have underestimated incidence of venous thromboembolism in users of combined oral contraceptives.Third- and second-generation oral contraceptives are associated with similar risk estimates for venous thromboembolism.Criteria for evaluating evidence that laboratory abnormalities are associated with the development of venous thromboembolism.Oral contraceptives, hormone replacement therapy and haemostasis.Venous thromboembolism in women taking hormonal contraceptives.New low-dose, extended-cycle pills with levonorgestrel and ethinyl estradiol: an evolutionary step in birth control.Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term.Endothelial function, endothelin-1, and fibrinogen in young women using the vaginal contraceptive ring.The prescription of isotretinoin to women: is every precaution taken?Current reversible contraceptive methods: a global perspective.Oral contraceptives and venous thromboembolism: which are the safest preparations available?Tentative guidelines and practical suggestions to avoid venous thromboembolism during oral contraceptive therapy.Combined oral contraceptives, smoking, and cardiovascular risk.Oral contraceptive use is associated with prostate cancer: an ecological study.Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databasesPharmacovigilance in the pharmaceutical industry.A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptivesValidation of the diagnosis of venous thromboembolism in general practice database studiesComparative study of the effects of combined oral contraceptives in hemostatic variables: an observational preliminary study.Family history of venous thromboembolism is a risk factor for venous thromboembolism in combined oral contraceptive users: a nationwide case-control studyRecurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy useDrospirenone: a novel progestin.Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.Venous thromboembolism in women.Hormonal contraception and risk of venous thromboembolism: national follow-up study.The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study.Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of general practice research database.Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis.Estrogen-free oral hormonal contraception: benefits of the progestin-only pill.
P2860
Q24198113-69049D3D-6146-41AB-AE0D-9D3D5D1DAE70Q24202769-FA20C058-FA0E-4DFC-A748-58B614811985Q24634077-E1C28051-13A0-4D69-859C-DD91DED02A51Q26767243-44B8F9FC-CF13-49E2-A480-CC34E0F26F06Q26995785-4BBBEDFF-6315-443F-962E-2921C7B434BDQ28266187-F7BAF6D1-8C61-4CE1-BC9C-1CA36B6CCB4BQ28266410-C6C6B059-20F9-4C98-9C57-83FB319C1611Q28344562-24CA1900-C01A-4BA4-A203-25631C0B344CQ33778866-CFF4050A-7511-4C1E-BEEB-5C230B0916D1Q33789636-CA13C159-BACF-459D-B395-D8F9195FC7F3Q33799389-6814E133-7CAC-49AE-91A7-837AA593D75CQ33816390-2B002F00-C549-43AC-9288-5C799C3021E1Q33932536-69945C5F-80E2-4CD5-B24B-AACBD265FFA2Q33954905-E19D58B3-5024-476D-B117-F54226A3FFC0Q34039827-D0F9715F-7924-4C93-8F20-D0B1DB3B57BEQ34097184-CD62518A-F8EE-43E6-8905-CE5405A7BA86Q34272169-4B08D37F-5F08-4DB6-B652-9E79512DF110Q34284224-D26708BA-E51F-4008-B833-B9CDD7E074A4Q34447839-84D48F99-8EBC-4D38-9079-1293D1A39C67Q34467497-38F7D1CB-A911-4969-BED9-075C7FD295C9Q34478867-B51A80DF-5DBE-4AB6-A244-82054F0A8CD4Q34743953-118635CF-8615-4848-9024-E32E0E49E077Q34743964-210BE42D-2328-4916-A748-0547852202DDQ35558094-6392A509-9D0C-496B-83C6-EAA29811628EQ35564878-5382A3EF-53EF-4BC4-BFDB-C7958C3EBDA9Q35651010-D3313990-B9B8-4DF2-94E8-AA3154FC06C9Q35802389-CB1610B0-DD6F-4EF1-8D1D-04E9B9B2E434Q36055436-64B89F48-4788-4F57-91FE-004726D86039Q36055463-38E94311-1F56-4333-8A2C-5132954362BBQ36153437-BEA9551C-5D17-4AFC-9494-C309FD7AB7E1Q36199544-E531CDBE-AC6F-4301-A31D-FDB51E23310FQ36800361-5D8ACD30-43BA-4955-9D8A-83763611A98CQ36808051-B08DF4EE-CB53-42C3-A95B-EB5E586C1ACBQ36887503-28EAD19C-C6B4-4D5C-B2A8-E93F826607CDQ37238147-C977FE7A-37D4-4C3D-ADDD-E1DF3F2B2C53Q37305290-72BD665F-FFA3-45BF-8986-BCDF2F5ED3B7Q37305295-9E50DDD4-730A-4FFE-9467-8ECD65D7D7B0Q37351686-2C975196-CC82-4E5B-9603-ED1E6FFA1CE3Q37363738-72A10DC0-FD59-4BA1-98D2-7D8BB435782CQ37809855-1EB0B59F-944F-4359-B9DF-E131987C0E15
P2860
Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Population-based study of risk ...... h various oral contraceptives.
@en
type
label
Population-based study of risk ...... h various oral contraceptives.
@en
prefLabel
Population-based study of risk ...... h various oral contraceptives.
@en
P2093
P1433
P1476
Population-based study of risk ...... h various oral contraceptives.
@en
P2093
C R Thompson
I R Hambleton
J G Kennedy
R A Lawrenson
R D Farmer
P356
10.1016/S0140-6736(96)07496-X
P407
P577
1997-01-01T00:00:00Z